Altintas Garip, Diken Adem Ilkay, Diken Ozlem Ercen, Hanedan Onur, Kucuker Seref Alp
Turkiye Yuksek Ihtisas Hospital, Department Of Cardiovascular Surgery, Ankara, Turkey.
Exp Clin Transplant. 2011 Feb;9(1):72-3.
Pneumocystis jiroveci is an important cause of mortality and morbidity among heart transplant recipients. This raises the question of prophylactic treatment for this infection. Trimethoprimsulfamethoxazole is commonly used in P. jiroveci pneumonia prophylaxis with mild to severe adverse effects. We present the use of inhaled pentamidine as P. jiroveci prophylaxis in a patient with an allergy to trimethoprim sulfamethoxazole.
耶氏肺孢子菌是心脏移植受者死亡和发病的重要原因。这就引发了针对这种感染进行预防性治疗的问题。复方新诺明常用于耶氏肺孢子菌肺炎的预防,但会有轻度至重度的不良反应。我们报告了一名对复方新诺明过敏的患者使用吸入性喷他脒进行耶氏肺孢子菌预防的情况。